Inflammation Biomarkers for Parkinson's Disease

Funding Agency:
Michael J. Fox Foundation for Parkinson's Research

The Michael J. Fox Foundation for Parkinson's Research seeks to support research that will develop new or improve upon existing biomarker tools for neuroinflammation/peripheral inflammation in Parkinson's disease (PD). The specific goals of this initiative are to: 1) facilitate the development of biomarker measures that can be utilized for novel target validation, 2) assess pathological progression or phenoconversion, or 3) identify inflammation paradigms unique to PD. Proposed biomarkers should facilitate objective decisions to validate a particular target or target efficacy marker (downstream readouts of successful target modification), improve the ability to enrich subject populations in clinical trials and/or determine whether experimental treatments are modifying the course of the disease, its symptoms or its progression.

Deadline for Pre-Proposals: May 31, 2017

Agency Website

Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

May 31, 2017